Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ambalalrabhai Enterprises's Enterprise Value is ₹3,900 Mil.
Ambalalrabhai Enterprises's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil. Therefore, Ambalalrabhai Enterprises's EV-to-FCF for today is .
The historical rank and industry rank for Ambalalrabhai Enterprises's EV-to-FCF or its related term are showing as below:
NSE:AMBALALSA'
s EV-to-FCF Range Over the Past 10 Years
Min: 0 Med: 0 Max: 54.14
Current: 54.14
During the past 13 years, the highest EV-to-FCF of Ambalalrabhai Enterprises was 54.14. The lowest was 0.00. And the median was 0.00.
NSE:AMBALALSA's EV-to-FCF is ranked worse than 75% of 564
companies
in the Drug Manufacturers industry
Industry Median: 21.825
vs NSE:AMBALALSA: 54.14
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ambalalrabhai Enterprises's PE Ratio (TTM) for today is calculated as:
Ambalalrabhai Enterprises's share price for today is ₹45.94.
Ambalalrabhai Enterprises's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.250.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ambalalrabhai Enterprises EV-to-FCF Related Terms
Ambalalrabhai Enterprises EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ambalalrabhai Enterprises's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambalalrabhai Enterprises EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ambalalrabhai Enterprises's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Ambalalrabhai Enterprises's EV-to-FCF falls into.
Ambalalrabhai Enterprises's current Enterprise Value is ₹3,900 Mil.
Ambalalrabhai Enterprises's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Ambalalrabhai Enterprises (NSE:AMBALALSA) Overvalued in 2026?
Based on GuruFocus' analysis, Ambalalrabhai Enterprises stock appears to be overvalued.
The current stock price of ₹45.94 is trading 9.5% above its estimated GF Value™ of ₹41.96.
GuruFocus considers Ambalalrabhai Enterprises to be Fairly Valued.
Key valuation signals for NSE:AMBALALSA:
EV-to-FCF:
GF Value™: ₹41.96 vs. price of ₹45.94 (9.5% above fair value)
No single metric tells the full story. See the NSE:AMBALALSA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambalal Sarabhai Enterprises Ltd is an India-based company engaged in the manufacturing and marketing of Drugs and Formulation. The operating segment of the company is Pharmaceutical Products. It serves domestic as well as International markets.
52GF Score
Get the complete analysis for NSE:AMBALALSA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AMBALALSA has been successfully added to your 
